Suppr超能文献

高级别前列腺上皮内瘤变和非典型小腺泡增生:当前临床实践中对癌症的预测价值。

High-grade prostatic intraepithelial neoplasia and atypical small acinar proliferation: predictive value for cancer in current practice.

作者信息

Schlesinger Cory, Bostwick David G, Iczkowski Kenneth A

机构信息

Bostwick Laboratories, Richmond, VA, USA.

出版信息

Am J Surg Pathol. 2005 Sep;29(9):1201-7. doi: 10.1097/01.pas.0000168178.48535.0d.

Abstract

In earlier studies, prostate cancer (PCa) has been reported to appear in 21% to 48% of subsequent biopsies for isolated high-grade prostatic intraepithelial neoplasia (PIN) and in 34% to 60% for isolated atypical small acinar proliferation suspicious for, but not diagnostic of, malignancy (ASAP). We report results of follow-up biopsies in a recent cohort of community practice patients who underwent biopsy for PSA abnormalities. The study group consisted of 336 men with initial diagnoses of PIN (n = 204), ASAP (n = 78), or both lesions (n = 54) who underwent at least one repeat biopsy. Mean follow-up intervals in months were 6.0 for PIN, 3.8 for ASAP, and 4.9 for PIN/ASAP. Follow-up PCa detection rates were 23%, 37%, and 33%, respectively. The predictive value of ASAP was significantly higher than that for PIN (P = 0.0188). In 23 PIN studies with chronologic midpoints in the early 1990s, follow-up PCa was detected in a mean of 36% of cases, whereas this value was 21% after the year 2000. In 13 ASAP studies, mean PCa detection on follow-up was 45% until 1996 and 39% from 1997 to present. PIN/ASAP predicted PCa in 33% of cases in our study, similar to ASAP alone (P = 0.65) and had a mean predictive value of 44% in the literature. Factors that may account for the decline in PIN predictive values include: 1) extended biopsy techniques that yield higher rates of initial cancer detection, 2) lower detection rate for the remaining small cancers that may accompany PIN, and 3) remaining PIN cases may lack concomitant cancer.

摘要

在早期研究中,据报道,在后续针对孤立性高级别前列腺上皮内瘤变(PIN)的活检中,前列腺癌(PCa)的出现率为21%至48%;在针对可疑但不能确诊为恶性肿瘤的孤立性非典型小腺泡增生(ASAP)的活检中,其出现率为34%至60%。我们报告了近期一组因前列腺特异性抗原(PSA)异常而接受活检的社区实践患者的随访活检结果。研究组由336名男性组成,他们最初被诊断为PIN(n = 204)、ASAP(n = 78)或同时患有这两种病变(n = 54),并接受了至少一次重复活检。PIN、ASAP、PIN/ASAP的平均随访间隔时间(以月为单位)分别为6.0、3.8和4.9。随访时PCa的检出率分别为23%、37%和33%。ASAP的预测价值显著高于PIN(P = 0.0188)。在23项于20世纪90年代初设定时间中点的PIN研究中,随访时PCa的平均检出率为36%,而在2000年后这一数值为21%。在13项ASAP研究中,截至1996年随访时PCa的平均检出率为45%,从1997年至今为39%。在我们的研究中,PIN/ASAP在33%的病例中预测了PCa,与单独的ASAP相似(P = 0.65),在文献中的平均预测价值为44%。可能导致PIN预测价值下降的因素包括:1)能提高初始癌症检出率的扩展活检技术;2)与PIN可能同时存在的其余小癌症的较低检出率;3)剩余的PIN病例可能不存在伴随的癌症。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验